Thank you for your reply. Congratulations to Parecoxib 40 mg powder for injection of CCPC for successfully obtaining TFDA approval. However, please understand that Parecoxib 40 mg powder for injection will be the fourth or fifth player to enter the Australian market, so it will face a certain degree of price challenge. At present, the gap between the price proposed by CCPC and the expected price (USD7.20 for a box of 10) is too large. Unfortunately, we have to suspend the cooperation of this project. Of course, we will continue to look for other cooperation opportunities, and we are very grateful to CCPC for its contribution and discussion on this case.
正在翻譯中..
